Deutsche Bank’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.2M Buy
1,032,316
+552,558
+115% +$16.4M 0.01% 847
2025
Q4
$14.9M Sell
479,758
-457,709
-49% -$12.6M ﹤0.01% 965
2025
Q3
$20.2M Buy
937,467
+550,529
+142% +$9.93M 0.01% 855
2025
Q2
$5.41M Sell
386,938
-9,870
-2% -$134K ﹤0.01% 1209
2025
Q1
$5.35M Sell
396,808
-6,066
-2% -$103K ﹤0.01% 1227
2024
Q4
$7.72M Buy
402,874
+23,327
+6% +$507K ﹤0.01% 1126
2024
Q3
$8.63M Buy
379,547
+331,102
+683% +$5.41M ﹤0.01% 1061
2024
Q2
$630K Buy
48,445
+1,672
+4% +$23.1K ﹤0.01% 2223
2024
Q1
$819K Buy
46,773
+3,982
+9% +$77.2K ﹤0.01% 2105
2023
Q4
$932K Buy
42,791
+20,768
+94% +$328K ﹤0.01% 2067
2023
Q3
$338K Sell
22,023
-70,631
-76% -$1.35M ﹤0.01% 2431
2023
Q2
$2.2M Sell
92,654
-161,460
-64% -$4.14M ﹤0.01% 1575
2023
Q1
$6.46M Buy
254,114
+237,028
+1,387% +$7.6M ﹤0.01% 1125
2022
Q4
$499K Buy
17,086
+6,005
+54% +$138K ﹤0.01% 2450
2022
Q3
$227K Sell
11,081
-1,687
-13% -$30.3K ﹤0.01% 2873
2022
Q2
$148K Buy
+12,768
New +$172K ﹤0.01% 3330
2020
Q1
Sell
-1,424
Closed -$10K 4858
2019
Q4
$10K Sell
1,424
-1,212
-46% -$12.4K ﹤0.01% 4499
2019
Q3
$28K Sell
2,636
-7,569
-74% -$167K ﹤0.01% 4206
2019
Q2
$313K Sell
10,205
-1,624
-14% -$65.2K ﹤0.01% 3567
2019
Q1
$494K Sell
11,829
-881
-7% -$39.9K ﹤0.01% 3458
2018
Q4
$577K Buy
12,710
+8,786
+224% +$508K ﹤0.01% 3236
2018
Q3
$328K Buy
3,924
+654
+20% +$61.7K ﹤0.01% 3998
2018
Q2
$315K Sell
3,270
-350
-10% -$37K ﹤0.01% 4076
2018
Q1
$380K Sell
3,620
-441
-11% -$47.9K ﹤0.01% 3867
2017
Q4
$634K Buy
4,061
+3,305
+437% +$421K ﹤0.01% 3483
2017
Q3
$102K Sell
756
-209
-22% -$35.2K ﹤0.01% 4161
2017
Q2
$185K Buy
+965
New +$163K ﹤0.01% 3968
2017
Q1
Sell
-71
Closed -$5K 5114
2016
Q4
$5K Buy
+71
New +$7.42K ﹤0.01% 4757

Other funds holding VRDN